scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1015293578 |
P356 | DOI | 10.1097/00004647-199603000-00007 |
P698 | PubMed publication ID | 8594054 |
P5875 | ResearchGate publication ID | 14606605 |
P2093 | author name string | Lee WH | |
Vannucci SJ | |||
Wang GM | |||
Seaman LB | |||
P2860 | cites work | Anatomy of the Human Ovarian Insulin-Like Growth Factor System | Q28297825 |
ADH-induced depolymerization of F-actin in the toad bladder granular cell: a confocal microscope study | Q33208201 | ||
Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts | Q33579190 | ||
A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury | Q34247862 | ||
Cell death and control of cell survival in the oligodendrocyte lineage | Q34460930 | ||
Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development | Q35589345 | ||
Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation | Q37617327 | ||
Neonatal asphyxia. II. Neonatal mortality and long-term sequelae | Q38524677 | ||
Monitoring of cerebral function after severe asphyxia in infancy | Q38947770 | ||
Seizures, hypoxic‐ischemic brain injury, and intraventricular hemorrhage in the newborn | Q40355134 | ||
IGF binding proteins and their functions | Q40490283 | ||
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons | Q42484843 | ||
Positron emission tomography in the asphyxiated term newborn: parasagittal impairment of cerebral blood flow | Q43734577 | ||
Insulin-like growth factors in the response to cerebral ischemia | Q47818821 | ||
Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse | Q48091462 | ||
Cerebral glucose and energy utilization during the evolution of hypoxic-ischemic brain damage in the immature rat. | Q48164851 | ||
The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. | Q48259779 | ||
Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury | Q48299926 | ||
Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice | Q48313440 | ||
Expression of insulin-like growth factor I by astrocytes in response to injury | Q48420953 | ||
Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. | Q48549457 | ||
Pathogenesis of hypoxic-ischemic brain injury in a perinatal rodent model | Q48632639 | ||
Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures | Q48651520 | ||
Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains | Q48722728 | ||
Reduction of perinatal hypoxic-ischemic brain damage with allopurinol | Q49029757 | ||
Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro. | Q51185222 | ||
P433 | issue | 2 | |
P921 | main subject | hypoxia | Q105688 |
P304 | page(s) | 227-236 | |
P577 | publication date | 1996-03-01 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia | |
P478 | volume | 16 |
Q28581618 | Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1 |
Q48443195 | Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain |
Q35634208 | Angiogenesis dysregulation in term asphyxiated newborns treated with hypothermia |
Q26744749 | Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology |
Q33947306 | Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury |
Q41560808 | Central nervous system resuscitation |
Q50231132 | Cerebral artery signal transduction mechanisms: developmental changes in dynamics and Ca2+ sensitivity |
Q49088590 | Characterization of three IGFBP mRNAs in Atlantic croaker and their regulation during hypoxic stress: potential mechanisms of their upregulation by hypoxia |
Q35827614 | Combination treatment with ethyl pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathy |
Q48797640 | Decreased IGF-I gene expression during the apoptosis of Purkinje cells in pcd mice |
Q53531244 | Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. |
Q35895419 | Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke |
Q54114693 | Estradiol Activates PI3K/Akt/GSK3 Pathway Under Chronic Neurodegenerative Conditions Triggered by Perinatal Asphyxia. |
Q77592376 | Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions |
Q38094638 | Generating new neurons to circumvent your fears: the role of IGF signaling. |
Q34312950 | Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults |
Q37479916 | IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions |
Q48552439 | IGF-I and microglia/macrophage proliferation in the ischemic mouse brain |
Q44813370 | IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors |
Q48172317 | Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors. |
Q44141730 | Inhibition of insulin-like growth factor I activity contributes to the premature apoptosis of cerebellar granule neuron in weaver mutant mice: in vitro analysis |
Q37710673 | Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury. |
Q89478133 | Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives |
Q33910877 | Insulin-like growth factor-I-stimulated Akt phosphorylation and oligodendrocyte progenitor cell survival require cholesterol-enriched membranes |
Q60542576 | Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection |
Q33977693 | Multiple molecular penumbras after focal cerebral ischemia |
Q48439915 | Neocortical and hippocampal glial fibrillary acidic protein immunoreactivity shows region-specific variation during the mouse estrous cycle |
Q30451424 | Neurodevelopmental effects of insulin-like growth factor signaling |
Q48403313 | Neurogenesis in explants from the walls of the lateral ventricle of adult bovine brain: role of endogenous IGF-1 as a survival factor. |
Q44361130 | Neuroprotective Effects of Insulin-Like Growth Factor-Binding Protein Ligand Inhibitors in Vitro and in Vivo |
Q37208889 | Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury |
Q73530524 | Perinatal hypoxia-ischemia decreased neuronal but increased cerebral vascular endothelial IGFBP3 expression |
Q48256639 | Possible protective role of growth hormone in hypoxia-ischemia in neonatal rats |
Q38346186 | Potential role of IGF-I in hypoxia tolerance using a rat hypoxic-ischemic model: activation of hypoxia-inducible factor 1alpha |
Q28570464 | Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas |
Q33919869 | Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke. |
Q43268755 | Role of glutamate and its receptors and insulin-like growth factors in hypoxia induced periventricular white matter injury |
Q33869813 | The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders |
Q47926510 | The effects of hypoxia on growth cones in the ovine fetal brain |
Q47175854 | The influence of litter size on brain damage caused by hypoxic-ischemic injury in the neonatal rat. |
Q37994953 | The many faces of insulin-like peptide signalling in the brain |
Q38344573 | The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders |
Q33701510 | The role of growth hormone and insulin-like growth factor I in the regulation of apoptosis |
Q41301869 | The role of the insulin-like growth factors in the central nervous system |
Q33186036 | Triiodothyronine is a survival factor for developing oligodendrocytes |
Search more.